Pharmaceuticals are crucial to
the protection of peoplefs lives and health,
contributing greatly to our quality of life
(QOL). Numerous diseases remain difficult to
treat, and a great many patients await new
developments in the hope that the future will
bring more effective medicines.
particularly so in Japan, which faces the issues
associated with an aging society. In order to
build an active society abundant in the joys of
life, it is crucial that we develop medicines to
treat so-called lifestyle-related illnesses, such
as cancer, heart disease and
Mebiopharm is a biotechnology
firm involved in the development of medicines that
hold promise for such a society, and we place a
particular emphasis on anticancer drugs with
special DDS capabilities.
As a company with
research and development as our foundation, our
mission is to develop revolutionary new liposome
products with special DDS capabilities. Working in
cooperation with domestic and international
universities and researchers our ultimate goal is
to contribute to the effectiveness of medical
practice and the QOL of people everywhere by
marketing these products worldwide.
Mebiopharm Co., Ltd.